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Abstract 32 
Background: A large fraction of the cost of conducting clinical trials is allocated to 33 
recruitment of participants. A synthesis of findings from studies that evaluate the cost 34 
and effectiveness of different recruitment strategies will inform investigators in designing 35 
cost-efficient clinical trials. 36 
Purpose:  Systematically identify, assess, and synthesize evidence from published 37 
comparisons of the cost and yield of strategies for recruitment of participants to health 38 
research studies. 39 
Methods: We included randomized studies in which two or more strategies for 40 
recruitment of participants had been compared. We focused our economic evaluation 41 
on studies that randomized participants to different recruitment strategies.  42 
Results: We identified 10 randomized studies that compared recruitment strategies, 43 
including monetary incentives (cash or prize), direct contact (letters or telephone call), 44 
and medical referral strategies. Only two of the 10 studies compared strategies for 45 
recruiting participants to clinical trials.  We found that allocating additional resources to 46 
recruit participants using monetary incentives or direct contact yielded between 4% and 47 
23% additional participants compared to using no strategies. For medical referral, 48 
recruitment of prostate cancer patients by nurses was cost-saving compared to 49 
recruitment by consultant urologists. For all underlying study designs, monetary 50 
incentives cost more than direct contact with potential participants, with a median 51 
incremental cost per recruitment ratio (ICER) of 72 (International dollar [Int$], a 52 
theoretical unit of currency) for monetary incentive strategy compared to 28 Int$ for 53 
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direct contact strategy. Only monetary incentives and source of referral were evaluated 54 
for recruiting participants into clinical trials.  55 
Limitations: We did not review studies that presented non-monetary cost or lost 56 
opportunity cost. We did not adjust for the number of study recruitment sites or the 57 
study duration in our economic evaluation analysis.  58 
Conclusions: Systematic and explicit reporting of cost and effectiveness of recruitment 59 
strategies from randomized comparisons is required to aid investigators to select cost-60 
efficient strategies for recruiting participants to health research studies including clinical 61 
trials. 62 
 63 
Key words: cost of conducting health research studies, recruitment, economic 64 
evaluation, recruitment, recruitment effectiveness, clinical trial efficiency  65 
 66 
67 
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Introduction 68 
 A large fraction of the cost of conducting health research studies including clinical 69 
trials lies in the recruitment of participants 1-3. Maximizing recruitment and ensuring high 70 
follow-up rates with minimal expenditure are important financially, ethically, and 71 
statistically (i.e., to obtain adequate statistical power for hypothesis testing or adequate 72 
precision) 4. In economics and operations research, efficiency is described as a set of 73 
structures and processes that aim to achieve high performance at minimal cost 5-7. In 74 
the context of the design and conduct of clinical trials, we consider efficiency as the 75 
minimal cost to carry out a trial while still achieving satisfactory statistical power.  76 
Approaches to improving the operational efficiency of clinical trials and 77 
approaches to enhancing clinical trial designs, study start-up, data quality, and adverse 78 
event reporting have been discussed in the literature 8. It is critical to employ design 79 
strategies that minimize costs while maintaining adequate power 9-11. More formally, 80 
cost-effectiveness models can be built to examine the trade-offs between cost and 81 
benefits of different methods for conducting a clinical trial while optimizing statistical 82 
power 12.  83 
 Recruiting participants to health research studies is resource intensive and has 84 
been recognized as a challenge by many investigators 13. Recruitment strategies can be 85 
broadly categorized as direct contact (e.g., telephone call to potential participants), 86 
community outreach, mass media, referrals, and incentives (e.g., cash or gift card to 87 
reimburse participants’ time) 14. Systematic reviews on strategies to recruit participants 88 
to research studies have been previously performed, but these reviews focused on the 89 
effectiveness of the strategies and did not report the cost of the recruitment15-18. Some 90 
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recruitment strategies may be more efficient than others, but cost more. The objective of 91 
this study was to systematically identify, assess, and synthesize studies that compared 92 
different recruitment strategies on the effectiveness and cost of recruitment.  93 
Methods 94 
We followed the Preferred Reporting Items for Systematic Reviews and Meta-95 
Analysis (PRISMA) in reporting our systematic review 19. 96 
Criteria for selecting studies 97 
 We included randomized controlled trials (RCTs) that had compared two or more 98 
operational processes, defined as strategies for recruiting participants into health 99 
research studies. To be eligible, a study must have reported monetary cost directly 100 
related to operational processes (recruitment of participants). We excluded studies that 101 
reported cost only in a non-monetary form or cost unrelated to participant recruitment, 102 
such as the cost to attend clinic for medical services (e.g., cost for national 103 
immunization programs or annual mammography examinations).  104 
Search strategy 105 
 We searched PubMed (1950 – 2010), the Cochrane Library (2010, Issue 4) 106 
which includes the Cochrane Methodology Register and the Cochrane Central Register 107 
of Controlled Trials (CENTRAL), Current Index to Statistics-Extended Database (CIS-108 
ED) (1967 – 2009), EMBASE (1980-2010), and ISI Web of Science (1900 – 2010) using 109 
a search strategy developed by LH and reviewed by a medical informationist. We also 110 
handsearched references of included studies, and contacted experts at the Johns 111 
Hopkins Center for Clinical Trials for any additional potentially eligible studies. We 112 
completed the search in August 2011. We used various terms related to study design, 113 
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recruitment  of participants, cost, and power. The complete search strategies are 114 
available in the web supplemental section (S1, which also include a parallel search for 115 
studies examining strategies for participant retention). 116 
Data collection and analysis 117 
Study selection process 118 
 Pairs of authors (LH, SHL, BJ, TL, and SSV) independently screened each 119 
abstract and reviewed full text of relevant abstracts resulting from the electronic search. 120 
We resolved disagreements by consensus or by arbitration by a third person.  121 
Data extraction 122 
 For data on underlying research study and the relationships of the authors’ 123 
affiliations and funding institutions, LH performed the initial data extraction, which was 124 
verified by SHL or BJ. For data on operational processes and quality assessment, LH, 125 
SHL and BJ performed independent data extraction. We resolved disagreements 126 
through discussion. We made up to three attempts to contact the primary authors for 127 
additional information or missing data on the costs of recruitment.  128 
 In this review, expanding on Silagy’s taxonomy, we classified recruitment 129 
strategies into the following categories: medical referral, community outreach, mass 130 
media, direct contact, personal referral, incentives, registry, and other 14. Medical 131 
referral refers to health professionals inviting participants to the study. Community 132 
outreach involves mobilizing the community to promote the study at local fairs, church 133 
or community organized events. Mass media refers to using public service 134 
announcements and advertisements to inform potential participants about the study. 135 
Direct contact involves mailing,  telephoning, or emailing potential participants. Personal 136 
8 
 
referral includes word of mouth referral by friends and family to the study. Incentives 137 
include cash or prizes for the participants’ time in the study. The registry category refers 138 
to the use of clinical databases to identify potential participants for the study. Examples 139 
of approaches classified as ‘other’ include recruitment at the worksite or using multiple 140 
recruitment approaches. 141 
Assessment of the risk of bias of included studies 142 
 We examined the method of randomization, allocation concealment, reporting of 143 
blinding to the operational processes, analysis by intention to treat, comparability of 144 
clinical recruitment site, methods for dealing with missing data, and definition of the 145 
operational process and outcome of the recruitment efforts 20. 146 
Analysis 147 
 We conducted a cost-effectiveness analysis and calculated incremental cost-148 
effectiveness ratios (ICERs) for each study. Equation 1 is the formula for computing the 149 
ICER. 150 
Equation 1:  ICER=
                                    
                                                              
 151 
The ICER is the effect of changing the recruitment strategy and the additional cost 152 
incurred compared to the less costly and less effective approach. The incremental cost 153 
is the difference between the total cost per eligible participant for strategy B and the 154 
total cost per eligible participant for strategy A. Strategy A was defined as the least 155 
costly and least effective strategy reported in the study. Strategy B was the comparator. 156 
In our analyses, the least costly and least effective strategy was usually the group that 157 
received no additional operational process. We used the total cost per eligible 158 
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participant to normalize our incremental cost, specifically for studies that had a 159 
randomization ratio other than 1:1.  160 
We used the number of participants recruited (screened) over the number 161 
randomized (eligible) or contacted as a measure of effectiveness of the strategies. The 162 
effectiveness was determined by the recruitment ratio. The incremental recruitment ratio 163 
is the difference between the recruitment ratio for strategy B and the recruitment ratio 164 
for strategy A. We conducted an expansion path analysis, based on the ICER, to 165 
identify the most cost-effective strategies. We used the cost-effectiveness threshold as 166 
a metric to assist investigators to choose among different strategies for recruitment of 167 
participants. The cost-effectiveness threshold value, which is undefined for operational 168 
process research, would be the value that investigators are willing to pay to recruit an 169 
additional participant into the study.  170 
 We first presented cost in the unit in which it was reported. We then adjusted for 171 
inflation to 2009 national currency using the consumer price index for each country. For 172 
studies that did not report the cost year, we assumed that the cost year is two years 173 
prior to the publication date on the assumption that it takes on average two years after 174 
study completion to publish in a peer-reviewed journal 21. We converted the national 175 
currency to the international dollar (Int$) using the purchasing power parity (PPP) index 176 
22. The Int$ is a theoretical unit, which allows us to compare across countries the cost of 177 
conducting the study, and to report the cost for all studies using a common unit. The 178 
PPP index is the number of units of a country’s currency needed to purchase the same 179 
amount of goods or services in the domestic market as the US dollar would buy in the 180 
United States 22.  181 
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 182 
Data management 183 
 We used Endnote version X.0.2 to store the bibliographic citations from the 184 
search and QUOSA Information Manager to retrieve the full text articles. We abstracted 185 
and entered data to a Microsoft Access® 2007 database developed specifically for this 186 
study. We used Stata® version 10.1 to analyze the data and to obtain key statistics and 187 
Microsoft Excel® 2007 for the cost-effectiveness analysis. 188 
Results 189 
Search 190 
 We identified 4,819 unique citations and excluded 4,381 after screening the titles 191 
and abstracts. We retrieved and screened the full-text reports for 448 titles and 192 
abstracts; the full-text reports were not available for the remaining 9 titles and abstracts. 193 
We excluded 434 full text reports for the following reasons: commentary/reviews (n=62), 194 
no operational comparator (n=252), no cost comparator (n=73), and no randomization 195 
of operational processes reported (n=47). In total, we included 10 studies in this review 196 
23-32 (see Figure 1).  Only two of the 10 studies 24, 28 were conducted to evaluate 197 
recruitment methods to a clinical trial of interventions. 198 
Overall description 199 
 The primary diseases studied in the included reports were prostate cancer, 200 
smoking cessation, breast cancer, ocular disorder, and abnormal pregnancy. Five 201 
(50%) studies enrolled both male and female participants; one (10%) study enrolled 202 
only male participants, and three (30%) studies recruited only female participants. Nine 203 
(90%) studies only enrolled adults and one study (10%) recruited children. Three (30%) 204 
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studies received funding from academic institution. Two (20%) studies received funding 205 
from government agencies. Two (20%) studies received funding from pharmaceutical 206 
companies. One (10%) study received both academic and government agency funding. 207 
A majority of the studies were conducted in the US (60%). Other study locations were 208 
Australia (30%) and Canada (10%).   209 
 The 10 included studies reported a total of 29 strategies for recruitment. Cost 210 
data came from retrospective review of the financial budgets. Table 1 provides a 211 
summary of the characteristics of the studies that randomized recruitment strategies. 212 
The overall recruitment duration ranged between 2 to 24 months. The median number 213 
of participants randomized was 443 (interquartile range [IQR]: 331 – 900). The median 214 
number of participants who responded to the recruitment strategies was 177 (IQR: 104 215 
– 483). The number of strategies that were compared ranged from 2 to 5.  216 
Quality assessment of the included studies 217 
 Of the 10 studies that randomized operational processes, only three studies 218 
reported the method for randomization. The risk of bias assessment can be found in the 219 
web supplemental section (Table S2). None of the studies described allocation 220 
concealment, blinding of the investigator, or methods for handling missing data. Three 221 
(30%) studies described an intention to treat analysis and three (30%) studies 222 
discussed comparability of the clinical recruitment sites. The definitions of the 223 
operational processes and cost measures were reported explicitly in all studies.  224 
Economic evaluation of strategies in the randomized studies 225 
 Six (60%) studies, including one conducted in the context of recruitment to a 226 
clinical trial28, assessed monetary incentives to recruit participants into the study. Three 227 
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(30%) studies implemented different methods of direct contact and one (10%) study24 228 
compared nurses with consultant urologists for recruiting participants to a clinical trial. 229 
Table 2 presents the cost-effectiveness results.  230 
 The median ICER for the six studies assessing monetary incentives was Int$72. 231 
The median ICER for the three direct contact studies was Int$28. The study populations 232 
for the six studies, which evaluated monetary incentives, were adolescents enrolled into 233 
a smoking cessation program 28, pharmacists 30, enrollees of health plans 31, and 234 
physicians 25, 32. The investigators compared incremental cash value to either no 235 
incentive or an incentive of lesser amount. Providing vouchers to pharmacists yielded 236 
the highest cost (Int$88). The incremental cost per recruitment ratio (ICER) was Int$466 237 
for the voucher group compared to no voucher.  238 
 In the smoking cessation program trial 28, the $200 prize was less cost-effective 239 
compared to the $2 incentive. An extended cost expansion analysis was conducted for 240 
the $2 incentive and the $15 incentive. The ICER was Int$13 for the $2 incentive group 241 
to enroll an additional individual into the smoking cessation study compared to the no 242 
incentive strategy and the ICER was Int$123 for the $15 incentive group to recruit an 243 
additional person into the study compared to the $2 incentive group.  244 
 One study evaluated medical referral and compared nurses and consultant 245 
urologists to recruit participants to a clinical trial 24. Having consultant urologists recruit 246 
male participants with prostate cancer into the study was more costly and less effective 247 
compared to nurses.  248 
 249 
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In a study about enrolling members of a health plan 31, the $5 incentive group 250 
had an ICER of Int$53 compared to the $2 incentive group. For the study to recruit 251 
general physicians, the $20 incentive group was dominated because it was more costly 252 
and less effective compared to the $10 incentive group.  253 
 In another study recruiting general internists and family practitioners 25, the $10 254 
incentive had an ICER of Int$72 compared to the $5 incentive group. For the study 255 
recruiting female cosmetologists 26, it was less expensive and more effective to enclose 256 
$1 in the envelope compared to no incentive. 257 
 For the three studies that chose direct contact to recruit participants 23, 27, 29, the 258 
median ICER was Int$28. These studies reached out to a general group of women 29, 259 
nurses 23, and the general public dwelling in Melbourne 27. Postal mail and interviews 260 
were used to recruit participants. The doorstep interview had a response rate greater 261 
than 50% with a total cost of Int$7037 27. The ICER for the doorstep interview was 262 
Int$57 which is the additional cost to implement the doorstep interview compared to 263 
telephone interview per unit increase in recruitment ratio. In the study that used different 264 
postage stamps, the large stamp had an ICER of Int$0.10 23. For another study using 265 
mail to recruit participants, sending out two letters was less expensive and more 266 
effective compared to the one letter plus phone call at 6 weeks 29.  267 
 We found that investing additional resources to recruit participants yielded 268 
between 5% and 23% additional participants recruited compared to no additional 269 
recruitment strategies. However, in two studies 28, 32, the $200 prize and the $20 270 
incentive were eliminated from consideration as a cost-effective strategy because they 271 
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had higher ICERs and were more costly and less effective compared to the $2 incentive 272 
and $10 incentive, respectively.  273 
We were unable to determine which recruitment strategies meet an acceptable 274 
cost-effectiveness threshold because an acceptable threshold value has yet to be 275 
defined. The heterogeneity in the included studies precluded us from identifying a 276 
specific threshold to which incentives are cost effective or a particularly cost effective 277 
strategy for recruitment. 278 
Discussion 279 
 Our systematic review synthesizes the existing evidence from randomized 280 
comparisons of recruitment strategies to reduce costs while maintaining the statistical 281 
power needed for a study. Only three strategies (monetary incentives, direct contact, 282 
and medical referral) had been assessed for recruitment of participants to randomized 283 
clinical trials. Based on the ICERs calculated for each study, we found that monetary 284 
incentives, in general, cost more than the direct contact and medical referral strategies. 285 
 Across all underlying study designs, monetary incentives increased the 286 
responses among the participants compared to no incentives but at an additional 287 
expense. Investigators who have a short time frame to recruit participants and adequate 288 
budget may consider using monetary incentives as a strategy. Increasing monetary 289 
incentives showed diminishing returns on the response or recruitment rate. That is, the 290 
cost-effectiveness diminished as incentives increased beyond a certain point. The 291 
trade-off that the health research study investigator faces is whether to offer a small 292 
incentive to recruit more participants or to prolong the duration for recruitment and incur 293 
the costs to maintain the recruitment sites. It should be noted that policies in some 294 
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countries33  and at some institutions prohibit monetary incentives apart from 295 
reimbursement for time and expenses directly associated with study participation. 296 
Our findings on monetary incentives as a strategy to increase enrollment are 297 
supported by other studies. Giuffrida et al. investigated financial incentives to enhance 298 
patient compliance 34 and found that financial incentives may improve patients’ 299 
compliance to medical treatment. In a systematic review by Treweek and colleagues, 300 
the authors reported that participants’ willingness to participate in the study increased 301 
with payments 15 In another study, lottery-style incentives did not increase complete 302 
response rates to postal questionnaires 35 which suggests that in addition to providing 303 
financial incentive, multiple factors affect recruitment.  304 
 We were unable to directly compare monetary incentives and direct contact 305 
strategies because the studies evaluating these strategies were conducted with different 306 
objectives. The two strategies may be effective for different reasons to different people 307 
– while monetary incentives may be appealing to younger participants because of the 308 
financial reward, others may prefer direct contact strategies that provides human 309 
interaction.   310 
The unit for comparison in this review was the monetary cost presented in 311 
standardized currency. We did not account for indirect costs such as overhead cost that 312 
may have been incurred by the investigators but not reported in the included studies. 313 
We did not include studies that presented non-monetary cost or lost opportunity cost. 314 
We did not adjust for the number of study recruitment sites in our cost calculation or 315 
measurement for effectiveness. Higher cost of recruitment could be associated with 316 
having multiple sites for recruitment. We did not account for the study duration in our 317 
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cost-effectiveness analysis. Finally, we did not explicitly distinguish between studies on 318 
recruiting participants for surveys versus other health research studies. We considered 319 
both types of studies to have the common goal of collecting data from participants.  320 
 Our findings highlight the need for conducting further research focused on 321 
comparing different strategies for recruitment of participants to clinical trials, 322 
disseminating the findings, and using them to design cost efficient trials. Currently, 323 
methodological investigations to compare different recruitment strategies are often low 324 
on the list of priorities for the researchers and the sponsors. Among the 10 included 325 
studies, only two studies24, 28 reported recruitment strategies to clinical trials. In addition, 326 
recommendations for standardized reporting of cost-effectiveness findings from RCTs 327 
on the cost of conducting clinical trials can ensure appropriate design of future trials 328 
through sharing of best practices. Furthermore, standardized reporting could minimize 329 
potential biases which may influence the credibility of the findings as observed in our 330 
risk of bias assessment. Appropriate choices of recruitment strategies during trial design 331 
could lead to cost-efficient clinical trials but comparative data from RCTs are needed to 332 
inform choices. Thus, investigators proposing to conduct clinical trials should be 333 
encouraged to include in their proposals a discussion on cost-effectiveness of the 334 
recruitment strategies they plan to adopt in the trial, enforcing which may require policy 335 
changes at the level of funding agencies. 336 
Conclusions 337 
 Monetary incentives, direct contact and medical referral are cost-effective 338 
strategies for recruiting participants to health research studies with a variety of designs. 339 
Recommendations for standardized reporting of findings from methodological studies on 340 
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cost-effectiveness of strategies for recruitment, retention, and follow-up of trial 341 
participants and a central resource to host the findings from such studies are necessary 342 
to support investigators to design high quality, cost-efficient health research studies 343 
including clinical trials. 344 
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Table 1. Characteristics of randomized studies that evaluated recruitment 1 
strategies 2 
 
Randomized (N=10) 
R
ef
. 
# 
First 
author
's last 
name 
Study title Ye
ar 
Underl
ying 
study 
design 
Primar
y 
diseas
e 
Objective 
of 
underlyin
g study  
Types of 
recruitme
nt 
strategie
s 
Overall 
recruitm
ent 
period 
(in 
months) 
N 
strateg
ies 
compa
red 
24
 Donov
an 
Who can best recruit to 
randomized trials? 
Randomized trial 
comparing surgeons and 
nurses recruiting patients 
to a trial of treatments for 
localized prostate cancer 
(the ProtecT study) 
20
03 
Clinical 
trial 
Prostat
e 
cancer 
Evaluate 
the 
feasibility 
of RCT of 
treatments 
of 
localized 
prostate 
cancer 
Medical 
referral 
24 2 
28
 Martin
son 
Effectiveness of monetary 
incentives for recruiting 
adolescents to an 
intervention trial to reduce 
smoking 
20
00 
Clinical 
trial 
Smokin
g 
cessati
on 
Reduce 
the 
prevalence 
of 30-day 
smoking 
by 
approximat
ely 5-6% 
through 
both 
preventing 
acquisition 
of smoking 
among 
smokers 
and 
encouragin
g 
cessation 
among 
smokers 
Monetary 
incentives 
2 4 
29
 Page Recruitment to 
mammography 
screening: a randomised 
trial and meta-analysis of 
invitation letters and 
telephone calls 
20
06 
Non-
RCT 
Breast 
cancer 
screeni
ng 
Investigate
s the 
effectivene
ss of two 
strategies 
compared 
with the 
standard 
practice of 
one 
invitation 
letter 
Direct 
contacts 
3 4 
27
 Living
ston 
Cost-effectiveness of 
recruitment methods in a 
population-based 
epidemiological study: the 
19
94 
Non-
RCT 
Ocular 
disorde
r 
Population
-based 
study 
designed 
Direct 
contacts 
3 2 
22 
 
 
Randomized (N=10) 
R
ef
. 
# 
First 
author
's last 
name 
Study title Ye
ar 
Underl
ying 
study 
design 
Primar
y 
diseas
e 
Objective 
of 
underlyin
g study  
Types of 
recruitme
nt 
strategie
s 
Overall 
recruitm
ent 
period 
(in 
months) 
N 
strateg
ies 
compa
red 
Melbourne Visual 
Impairment Project 
to increase 
our 
understan
ding of the 
prevalence 
and 
severity of 
major 
ocular 
diseases 
23
 Choi Effects of Mailing 
Strategies on Response 
Rate, Response Time, 
and Cost in a 
Questionnaire Study 
among Nurses 
19
90 
Survey Abnorm
al 
pregna
ncy 
Determine 
the most 
efficient 
mailing 
strategy 
for a postal 
questionna
ire study 
among 
nurses 
Direct 
contacts 
NR 5 
30
 Paul A monetary incentive 
increases postal survey 
response rates for 
pharmacists 
20
05 
Survey Smokin
g 
cessati
on 
Examine 
response 
rate for 
completion 
of postal 
survey 
Monetary 
incentives 
NR 2 
31
 Shaw The use of monetary 
incentives in a community 
survey: impact on 
response rates, data 
quality, and cost 
20
01 
Survey Genera
l health 
Assess the 
effect of 
incentive 
size on 
response 
rates, data 
quality, 
and cost 
Monetary 
incentives 
NR 2 
32
 VanG
eest 
Effects of different 
monetary incentives on 
the return rate of a 
national mail survey of 
physicians 
20
01 
Survey NA Seeks to 
further 
examine 
the effects 
of 
incentive 
size on 
response 
rates to a 
national 
mail 
survey of 
physicians 
Monetary 
incentives 
NR 3 
25, 
36
 
Halper
n 
Randomized Trial of $5 
versus $10 Monetary 
Incentives, Envelope 
Size, and Candy to 
20
02 
Survey NA Assess 
three 
strategies 
to increase 
Monetary 
incentives 
NR 2 
23 
 
 
Randomized (N=10) 
R
ef
. 
# 
First 
author
's last 
name 
Study title Ye
ar 
Underl
ying 
study 
design 
Primar
y 
diseas
e 
Objective 
of 
underlyin
g study  
Types of 
recruitme
nt 
strategie
s 
Overall 
recruitm
ent 
period 
(in 
months) 
N 
strateg
ies 
compa
red 
Increase Physician 
Response Rates to 
Mailed Questionnaires 
response 
rates to 
mailed 
physician 
surveys 
26
 John Effect of a Monetary 
Incentive on Response to 
a Mail Survey 
19
94 
Survey Pregna
ncy and 
women 
health 
Assess the 
effect of a 
monetary 
incentive 
in a larger 
population 
Monetary 
incentives 
3 3 
 1 
Abbreviation: Not reported = NR; Not applicable = NA 2 
  3 
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Table 2. Cost-effectiveness analysis for randomized studies 1 
 2 
Monetary incentives (N=6) 
Ref. 
# 
Strate
gy 
Ye
ar 
Curre
ncy 
Duratio
n of 
recruit
ment (in 
months
) 
N 
people 
random
ized 
N 
people 
respon
ded 
Recruit
ment 
ratio 
Int $ Cost 
per 
random
ized
1
 
Cost 
per 
respon
ded
2
 
Increme
ntal 
cost 
per 
recruit
ment 
ratio 
28
 No 
incenti
ve 
200
8 
USD 2 1050 483 0.46 533
2 
5.08 11.04  
 $200 
prize 
200
8 
USD 2 1050 589 0.56 733
9 
6.99 12.46 18.94 
 $2 200
8 
USD 2 1050 650 0.62 743
9 
7.09 11.45 1.65 
 $15 200
8 
USD 2 1050 721 0.69 161
85 
15.41 22.45 123.18 
30
 No 
vouch
er 
200
3 
USD NR 331 177 0.53 0 0.00 0.00  
 Vouch
er 
200
3 
USD NR 334 220 0.66 192
69 
57.69 87.59 465.49 
31
 $2 200
1 
USD NR 900 590 0.66 570
8 
6.34 9.67  
 $5 200
1 
USD NR 900 649 0.72 882
9 
9.81 13.60 52.89 
32
 $5 199
9 
USD NR 292 176 0.60 380
5 
13.03 21.62  
 $20 199
9 
USD NR 291 189 0.65 934
9 
32.13 49.47 408.51 
 $10 199
9 
USD NR 290 198 0.68 510
3 
17.60 25.77 -436.67 
36
 $5 200
0 
USD NR 700 354 0.51 539
8 
7.71 15.25  
 $10 200
0 
USD NR 500 293 0.59 674
6 
13.49 23.02 71.99 
26
 No 
incenti
ve 
198
8 
USD 3 443 327 0.74 191
5 
4.32 5.86  
26
 $1 
enclos
ed 
with 
2nd 
mailin
g 
198
8 
USD 3 4315 3385 0.78 149
79 
3.47 4.43 -18.40 
26
 $1 
enclos
ed 
with 
first 
mailin
g 
198
8 
USD 3 2791 2257 0.81 124
43 
4.46 5.51 40.79 
 3 
25 
 
Direct contact (N=3) 
R
ef
. 
# 
Strateg
y 
Ye
ar 
Curre
ncy 
Duratio
n of 
recruit
ment (in 
months
) 
N 
people 
random
ized 
N 
people 
respon
ded 
Recruit
ment 
ratio 
Int $ Cost 
per 
random
ized 
Cost 
per 
respon
ded 
Increme
ntal 
cost 
per 
recruit
ment 
ratio 
23
 No 
stamp 
199
8 
USD NR 400 104 0.26 372 0.93 3.58  
 Busines
s reply 
stamp 
199
8 
USD NR 400 132 0.33 443 1.11 3.36 2.53 
 Metered 
stamp 
199
8 
USD NR 400 149 0.37 577 1.44 3.87 7.87 
 Small 
regular 
stamp 
199
8 
USD NR 400 159 0.40 585 1.46 3.68 0.80 
 Large 
stamp 
199
8 
USD NR 400 173 0.43 586 1.47 3.39 0.10 
27
 Telepho
ne 
intervie
w 
199
2 
AUD 3 216 86 0.40 450
0 
20.83 52.33  
 Doorste
p 
intervie
w 
199
2 
AUD 3 256 132 0.52 703
7 
27.49 53.31 56.66 
29
 No 
intervent
ion 
200
4 
AUD 3 788 11 0.01 0 0.00 0.00  
 One 
letter 
200
4 
AUD 3 786 43 0.05 0 0.00 0.00  
 One 
letter 
plus 
phone 
call at 
six 
weeks 
200
4 
AUD 3 785 61 0.08 110
6 
1.41 18.14 61.28 
 Two 
letters 
200
4 
AUD 3 785 67 0.09 503 0.64 7.51 -100.51 
 1 
 2 
 3 
Medical referral (N=1) 
Re
f. 
# 
Strateg
y 
Ye
ar 
Curre
ncy 
Duratio
n of 
recruit
ment 
(in 
N 
people 
random
ized 
N 
people 
respon
ded 
Recruit
ment 
ratio 
Int$ Cost 
per 
random
ized 
Cost 
per 
respon
ded 
Increme
ntal 
cost per 
recruit
ment 
26 
 
months
) 
ratio 
24
 Nurse 200
1 
GBP 24 75 61 0.81 377
2 
50.29 61.83  
 Consult
ant 
urologis
t 
200
1 
GBP 24 75 53 0.71 389
7 
51.96 73.53 -15.71 
1
 The cost per randomized is calculated by dividing the cost (Int$) by the number of people randomized. 1 
2
 The cost per responded is calculated by dividing the cost (Int$) by the number of people responded. 2 
 3 
Figure 1. Flow diagram for study selection 4 
 5 
 6 
Articles identified and screened 
from database search: 
4,804
Studies retrieved for full-text 
evaluation: 453
Articles excluded after title and 
abstract screening: 4,381
Articles excluded after full-text 
evaluation against eligibility 
criteria: 443
• No full-text: 9
• Commentary/reviews: 62
• No operational comparator: 252
• No cost comparator: 73
• No randomization: 47 
Studies identified from 
handsearching: 
15
Studies included for systematic 
review: 10
